FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $324,000 | +45.3% | 40,000 | 0.0% | 0.18% | +60.4% |
| Q2 2022 | $223,000 | -0.4% | 40,000 | 0.0% | 0.11% | +20.7% |
| Q1 2022 | $224,000 | +27.3% | 40,000 | 0.0% | 0.09% | +17.9% |
| Q4 2021 | $176,000 | -53.3% | 40,000 | 0.0% | 0.08% | -61.4% |
| Q3 2021 | $377,000 | +29.1% | 40,000 | 0.0% | 0.20% | +27.8% |
| Q2 2021 | $292,000 | +17.7% | 40,000 | 0.0% | 0.16% | -7.1% |
| Q1 2021 | $248,000 | -16.8% | 40,000 | 0.0% | 0.17% | -34.4% |
| Q4 2020 | $298,000 | – | 40,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |